References
- Applebaum MA, Goldsby R, Neuhaus J, Dubois SG (2012). Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement. Pediatr Blood Cancer, 59, 617-20. https://doi.org/10.1002/pbc.24053
- Cheung R (2012). Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: a US SEER data analysis. Asian Pac J Cancer Prev, 13, 4587-91. https://doi.org/10.7314/APJCP.2012.13.9.4587
- Cheung R, Altschuler MD, D'Amico AV, et al (2001). ROCoptimization may improve risk stratification of prostate cancer patients. Urology, 57, 286-90. https://doi.org/10.1016/S0090-4295(00)00911-0
- Cheung R, Altschuler MD, D'Amico AV, et al (2001). Using the receiver operator characteristic curve to select pretreatment and pathologic predictors for early and late post-prostatectomy PSA failure. Urology, 58, 400-5. https://doi.org/10.1016/S0090-4295(01)01209-2
- D'Amico AV, Desjardin A, Chung A, et al (1998). Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer, 82, 1887-96. https://doi.org/10.1002/(SICI)1097-0142(19980515)82:10<1887::AID-CNCR11>3.0.CO;2-P
- Friedman DL, Whitton J, Leisenring W, et al (2010). Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst, 102, 1083-95. https://doi.org/10.1093/jnci/djq238
- Hanley JA, McNeil BJ (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiol, 143, 29-36. https://doi.org/10.1148/radiology.143.1.7063747
- Herzog CE (2005). Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol, 27, 215-8. https://doi.org/10.1097/01.mph.0000161762.53175.e4
- Jawad MU, Haleem AA, Scully SP (2011). Malignant sarcoma of the pelvic bones: treatment outcomes and prognostic factors vary by histopathology. Cancer, 117, 1529-41. https://doi.org/10.1002/cncr.25684
- Mukherjee D, Chaichana KL, Adogwa O, et al (2011). Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database. World Neurosurg, 76, 580-5. https://doi.org/10.1016/j.wneu.2011.05.016
- Mukherjee D, Chaichana KL, Gokaslan ZL, et al (2011). Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003. J Neurosurg Spine, 14, 143-50. https://doi.org/10.3171/2010.10.SPINE10189
- Schrager J, Patzer RE, Mink PJ, Ward KC, Goodman M (2011). Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007. J Registry Manag, 38, 153-61.
- Sultan I, Rihani R, Hazin R, Rodriguez-Galindo C (2010). Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study. Acta Oncol, 49, 237-44. https://doi.org/10.3109/02841860903253538
- Worch J, Cyrus J, Goldsby R, et al (2011). Racial differences in the incidence of mesenchymal tumors associated with EWSR1 translocation. Cancer Epidemiol Biomarkers Prev, 20, 449-53. https://doi.org/10.1158/1055-9965.EPI-10-1170
- Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG (2010). Ethnic and racial differences in patients with Ewing sarcoma. Cancer, 116, 983-8. https://doi.org/10.1002/cncr.24865
Cited by
- Wnt/β-catenin pathway in bone cancers vol.35, pp.10, 2014, https://doi.org/10.1007/s13277-014-2433-8
- Optimization of Decision Support Tool using Medication Regimens to Assess Rehospitalization Risks vol.5, pp.3, 2014, https://doi.org/10.4338/ACI-2014-04-RA-0040
- Analysis of SEER Adenosquamous Carcinoma Data to Identify Cause Specific Survival Predictors and Socioeconomic Disparities vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.347
- Analysis of SEER Glassy Cell Carcinoma Data: Underuse of Radiotherapy and Predicators of Cause Specific Survival vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.353
- Resveratrol in management of bone and spinal cancers pp.1478-6427, 2017, https://doi.org/10.1080/14786419.2017.1389936